Re patents, read the Hyperopia response to Bright Boy at the top of the board.
Yet they can not stop APAC from selling Apceden, a near identical (leuko+monocytes+GM-CSF+IL-4+tomour+freeze-thaw) product. Nobody can say how their product differs. Nobody can say why NWBO does not take action.
When asked about IP protection years ago, LP dodged by saying NWBO owns the dataset (true). Did not want to say if any patents actually a product developed 18 years ago.
Market Data 
Markets 
AI
